Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Heldman

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Pharmacology|February 22, 1996
Pharmacological basis for functional selectivity of partial muscarinic receptor agonistsE Heldman, J Barg, A Fisher, et al.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|September 1, 1991
Extracellular matrix permits the expression of von Willebrand's factor, uptake of di-I-acetylated low density lipoprotein and secretion of prostacyclin in cultures of endothelial cells from rat brain microvesselsD A Doron, D M Jacobowitz, E Heldman, et al.
Brain Research|February 8, 1991
Lipopolysaccharide-induced production of tumor necrosis factor activity in rats with and without risk factors for strokeJ M Hallenbeck, A J Dutka, S N Vogel, et al.
Annals of the New York Academy of Sciences|December 29, 1995
Dehydroepiandrosterone augments M1-muscarinic receptor-stimulated amyloid precursor protein secretion in desensitized PC12M1 cellsH D Danenberg, R Haring, E Heldman, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's diseaseA Fisher, R Brandeis, I Karton, et al.
European Journal of Pharmacology|December 12, 1995
Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamidesJ Barg, E Fride, L Hanus, et al.
Stroke|November 1, 1992
Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto ratsA L Sirén, E Heldman, D Doron, et al.
Annals of the New York Academy of Sciences|September 24, 1993
Selective signaling via unique M1 muscarinic agonistsA Fisher, E Heldman, D Gurwitz, et al.
Drug Design and Discovery|January 1, 1993
Progress in medicinal chemistry of novel selective muscarinic agonistsA Fisher, Y Karton, E Heldman, et al.
Brain Research|June 6, 1994
Agonist-stimulated release of von Willebrand factor and procoagulant factor VIII in rats with and without risk factors for strokeR M McCarron, D A Doron, A L Sirén, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Pharmacology|February 22, 1996
Pharmacological basis for functional selectivity of partial muscarinic receptor agonistsE Heldman, J Barg, A Fisher, et al.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|September 1, 1991
Extracellular matrix permits the expression of von Willebrand's factor, uptake of di-I-acetylated low density lipoprotein and secretion of prostacyclin in cultures of endothelial cells from rat brain microvesselsD A Doron, D M Jacobowitz, E Heldman, et al.
Brain Research|February 8, 1991
Lipopolysaccharide-induced production of tumor necrosis factor activity in rats with and without risk factors for strokeJ M Hallenbeck, A J Dutka, S N Vogel, et al.
Annals of the New York Academy of Sciences|December 29, 1995
Dehydroepiandrosterone augments M1-muscarinic receptor-stimulated amyloid precursor protein secretion in desensitized PC12M1 cellsH D Danenberg, R Haring, E Heldman, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's diseaseA Fisher, R Brandeis, I Karton, et al.
European Journal of Pharmacology|December 12, 1995
Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamidesJ Barg, E Fride, L Hanus, et al.
Stroke|November 1, 1992
Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto ratsA L Sirén, E Heldman, D Doron, et al.
Annals of the New York Academy of Sciences|September 24, 1993
Selective signaling via unique M1 muscarinic agonistsA Fisher, E Heldman, D Gurwitz, et al.
Drug Design and Discovery|January 1, 1993
Progress in medicinal chemistry of novel selective muscarinic agonistsA Fisher, Y Karton, E Heldman, et al.
Brain Research|June 6, 1994
Agonist-stimulated release of von Willebrand factor and procoagulant factor VIII in rats with and without risk factors for strokeR M McCarron, D A Doron, A L Sirén, et al.
Pageof 6